Phase I trial of a first-in-class ATR inhibitor VX-970 as monotherapy (mono) or in combination (combo) with carboplatin (CP) incorporating pharmacodynamics (PD) studies

• Published in: Journal of clinical oncology Vol. 34; no. 15_suppl; p. 2504
• Main Authors: O'Carrigan, Brent, de Miguel Luken, Maria Jose, Papadatos-Pastos, Dionysios, Brown, Jessica, Tunariu, Nina, Perez Lopez, Raquel, Ganegoda, Mahesha, Riisnaes, Ruth, Figueiredo, Ines, Carreira, Suzanne, Hare, Brian, Yang, Fang, McDermott, Katherine, Penney, Marina S., Pollard, John, Lopez, Juanita Suzanne, Banerji, Udai, De Bono, Johann S., Fields, Scott Z., Yap, Timothy Anthony
• Format: Journal Article
• Language: English
• Published: 20.05.2016

Abstract only